Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer

News
2020
2019
Archive

April 8, 2020

Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer
April 7, 2020

Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer
March 26, 2020

Pear Therapeutics Obtains FDA Authorization for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults With Chronic Insomnia
March 26, 2020

Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics
March 18, 2020

IDEAYA and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Binimetinib in Solid Tumors Harboring GNAQ or GNA11 Hotspot Mutations
March 18, 2020

IDEAYA Biosciences Announces IDE196 Monotherapy Phase 2 Does Selection and Clinical Program Update
March 16, 2020

Homology Medicines Announces Peer-Reviewed Publication of HMI-102 Investigational Gene Therapy Demonstrating Restoration of Normal Metabolic Pathway in PKU Disease Model
March 12, 2020

IDEAYA Biosciences and Cancer Research UK Announce Expanded Research Collaboration for PARG, a DDR-Based Synthetic Lethality Target, Evaluating DNA Replication Vulnerabilities
March 3, 2020

Akouos Closes $105 Million Series B Financing
February 28, 2020

RareCyte Announces the First Blood-to-Result PD-L1 Circulating Tumor Cell Assay